Activation	O
of	O
signal	O
transduction	O
and	O
apoptosis	O
in	O
healthy	B-cell_type
lymphomonocytes	I-cell_type
exposed	O
to	O
bystander	O
HIV-1-infected	B-cell_type
cells	I-cell_type
.	O

Persistent	O
activation	O
of	O
the	O
immune	O
system	O
is	O
one	O
of	O
the	O
hallmarks	O
of	O
HIV-1	O
infection	O
.	O

In	O
this	O
study	O
we	O
analysed	O
the	O
induction	O
of	O
factors	O
involved	O
in	O
cytokine	O
signal	O
transduction	O
,	O
such	O
as	O
STAT	B-protein
1	I-protein
proteins	I-protein
and	O
IRF-1	B-RNA
mRNA	I-RNA
,	O
in	O
normal	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
(	O
PBMC	B-cell_type
)	O
exposed	O
to	O
HIV-infected	B-cell_type
cells	I-cell_type
,	O
and	O
the	O
induction	O
of	O
apoptosis	O
.	O

Western	O
blot	O
analyses	O
and	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
results	O
indicate	O
that	O
both	O
cells	O
infected	O
with	O
a	O
X4	O
strain	O
and	O
cells	O
infected	O
with	O
a	O
R5	O
strain	O
are	O
able	O
to	O
increase	O
intracellular	O
levels	O
of	O
STAT	B-protein
1alpha	I-protein
and	I-protein
beta	I-protein
proteins	O
as	O
well	O
as	O
IRF-1	B-RNA
mRNA	I-RNA
.	O

This	O
effect	O
was	O
prevented	O
by	O
neutralizing	O
antibodies	O
against	O
interferon-alpha	B-protein
(	O
IFN-alpha	B-protein
)	O
.	O

HIV-1-infected	B-cell_type
cells	I-cell_type
dose-dependently	O
induced	O
apoptotic	O
commitment	O
in	O
normal	B-cell_type
PBMC	I-cell_type
,	O
as	O
revealed	O
by	O
DNA	O
fragmentation	O
analysis	O
,	O
but	O
this	O
was	O
not	O
accompanied	O
by	O
an	O
increase	O
of	O
caspase-3	O
activity	O
,	O
even	O
if	O
a	O
slight	O
up-regulation	O
of	O
IL-1beta-converting	B-RNA
enzyme	I-RNA
mRNA	I-RNA
was	O
detected	O
.	O

Apoptosis	O
induction	O
could	O
be	O
abrogated	O
mainly	O
by	O
antibodies	B-protein
against	O
tumour	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
by	O
antibodies	B-protein
against	O
IFN-gamma	B-protein
.	O

All	O
these	O
findings	O
suggest	O
that	O
uninfected	B-cell_type
PBMC	I-cell_type
can	O
undergo	O
activation	O
of	O
signal	O
transduction	O
and	O
apoptosis	O
after	O
exposure	O
to	O
bystander	O
HIV-infected	B-cell_type
cells	I-cell_type
,	O
subsequent	O
to	O
the	O
induction	O
of	O
cytokines	B-protein
such	O
as	O
IFNs	B-protein
and	O
TNF-alpha	B-protein
.	O

Clin	NULL
Exp	NULL
Immunol	NULL
2000	NULL
;	NULL
122:374-380	NULL
Activation	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
apoptosis	NULL
in	NULL
healthy	NULL
lymphomonocytes	NULL
exposed	NULL
to	NULL
bystander	NULL
HIV-1-infected	NULL
cells	NULL
I.	NULL
ABBATE*	NULL
,	NULL
F.	NULL
DIANZANIt	NULL
&	NULL
M.	NULL
R.	NULL
CAPOBIANCHI	NULL
National	NULL
Institute	NULL
for	NULL
Infectious	NULL
Diseases	NULL
,	NULL
L.	NULL
Spallanzani	NULL
'	NULL
I.	NULL
R.	NULL
C.	NULL
C.	NULL
S.	NULL
,	NULL
Laboratory	NULL
of	NULL
Virology	NULL
,	NULL
*Laboratory	NULL
of	NULL
Microbiology	NULL
,	NULL
S.	NULL
Pertini	NULL
Hospital	NULL
,	NULL
and	NULL
{	NULL
Libera	NULL
Universita	NULL
Campus	NULL
Biomedico	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
(	NULL
Accepted	NULL
for	NULL
publication	NULL
25	NULL
July	NULL
2000	NULL
)	NULL
SUMMARY	NULL
Persistent	NULL
activation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
is	NULL
one	NULL
of	NULL
the	NULL
hallmarks	NULL
of	NULL
HIV-1	NULL
infection	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
analysed	NULL
the	NULL
induction	NULL
of	NULL
factors	NULL
involved	NULL
in	NULL
cytokine	NULL
signal	NULL
transduction	NULL
,	NULL
such	NULL
as	NULL
STAT	NULL
1	NULL
proteins	NULL
and	NULL
IRF-1	NULL
mRNA	NULL
,	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
exposed	NULL
to	NULL
HIV-infected	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
and	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
X4	NULL
strain	NULL
and	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
R5	NULL
strain	NULL
are	NULL
able	NULL
to	NULL
increase	NULL
intracellular	NULL
levels	NULL
of	NULL
STAT	NULL
la	NULL
and	NULL
B	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
IRF-1	NULL
mRNA	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
prevented	NULL
by	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
interferon-alpha	NULL
(	NULL
IFN-	NULL
)	NULL
.	NULL

HIV-l-infected	NULL
cells	NULL
dose-dependently	NULL
induced	NULL
apoptotic	NULL
commitment	NULL
in	NULL
normal	NULL
PBMC	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
DNA	NULL
fragmentation	NULL
analysis	NULL
,	NULL
but	NULL
this	NULL
was	NULL
not	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
of	NULL
caspase-3	NULL
activity	NULL
,	NULL
even	NULL
if	NULL
a	NULL
slight	NULL
up-regulation	NULL
of	NULL
IL-1	NULL
B-converting	NULL
enzyme	NULL
mRNA	NULL
was	NULL
detected	NULL
.	NULL

Apoptosis	NULL
induction	NULL
could	NULL
be	NULL
abrogated	NULL
mainly	NULL
by	NULL
antibodies	NULL
against	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
by	NULL
antibodies	NULL
against	NULL
IFN-y	NULL
.	NULL

All	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
uninfected	NULL
PBMC	NULL
can	NULL
undergo	NULL
activation	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
apoptosis	NULL
after	NULL
exposure	NULL
to	NULL
bystander	NULL
HIV-infected	NULL
cells	NULL
,	NULL
subsequent	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IFNs	NULL
and	NULL
TNF-a	NULL
.	NULL

Keywords	NULL
-	NULL
signal	NULL
transduction	NULL
-	NULL
cytokines	NULL
INTRODUCTION	NULL
A	NULL
persistent	NULL
and	NULL
inappropriate	NULL
activation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
is	NULL
commonly	NULL
thought	NULL
to	NULL
represent	NULL
one	NULL
of	NULL
the	NULL
indirect	NULL
mechanisms	NULL
involved	NULL
in	NULL
progressive	NULL
disappearance	NULL
of	NULL
T	NULL
lymphocytes	NULL
caused	NULL
by	NULL
HIV-1	NULL
[	NULL
1-3	NULL
]	NULL
.	NULL

The	NULL
chronic	NULL
lymphomonocyte	NULL
activation	NULL
is	NULL
characterized	NULL
by	NULL
:	NULL
increased	NULL
expression	NULL
of	NULL
cell	NULL
activation	NULL
markers	NULL
;	NULL
altered	NULL
lymphoproliferative	NULL
response	NULL
;	NULL
secretion	NULL
of	NULL
a	NULL
peculiar	NULL
pattern	NULL
of	NULL
cytokines	NULL
;	NULL
B	NULL
cell	NULL
polyclonal	NULL
activation	NULL
;	NULL
increased	NULL
commitment	NULL
to	NULL
apoptosis	NULL
[	NULL
2,4-7	NULL
]	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
the	NULL
HIV-1	NULL
glycoprotein	NULL
gp120	NULL
is	NULL
considered	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
gp120	NULL
,	NULL
through	NULL
its	NULL
binding	NULL
to	NULL
CD4	NULL
,	NULL
is	NULL
able	NULL
to	NULL
impair	NULL
TCR-CD3	NULL
signalling	NULL
,	NULL
both	NULL
as	NULL
a	NULL
result	NULL
of	NULL
physical	NULL
dissociation	NULL
of	NULL
p56-Ick	NULL
from	NULL
CD4	NULL
,	NULL
and	NULL
as	NULL
consequence	NULL
of	NULL
direct	NULL
activation	NULL
of	NULL
ZAP-70	NULL
PTK	NULL
[	NULL
8,9	NULL
]	NULL
.	NULL

Other	NULL
effects	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
gp120	NULL
to	NULL
coreceptors	NULL
such	NULL
as	NULL
gal-cer	NULL
[	NULL
10	NULL
]	NULL
or	NULL
chemokine	NULL
receptors	NULL
(	NULL
manu-script	NULL
in	NULL
preparation	NULL
and	NULL
[	NULL
11	NULL
]	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
gp120	NULL
stimulates	NULL
the	NULL
release	NULL
of	NULL
interferon-alpha	NULL
(	NULL
IFN-a	NULL
)	NULL
and	NULL
IFN-y	NULL
,	NULL
IL-6	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
IL-1	NULL
,	NULL
IL-10	NULL
,	NULL
IL-8	NULL
and	NULL
RANTES	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
an	NULL
altered	NULL
cytokine	NULL
profile	NULL
that	NULL
roughly	NULL
corresponds	NULL
Correspondence	NULL
:	NULL
Maria	NULL
R.	NULL
Capobianchi	NULL
PhD	NULL
,	NULL
National	NULL
Institute	NULL
for	NULL
Infectious	NULL
Diseases	NULL
'	NULL
L	NULL
.	NULL

Spallanzani	NULL
'	NULL
I.	NULL
R.	NULL
C.	NULL
C.	NULL
S.	NULL
,	NULL
Laboratory	NULL
of	NULL
Virology	NULL
,	NULL
Via	NULL
Portuense	NULL
,	NULL
292-00149	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

E-mail	NULL
:	NULL
mreapobianchi	NULL
@	NULL
libero.it	NULL
374	NULL
apoptosis	NULL
HIV-1	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
plasma	NULL
of	NULL
HIV-l-infected	NULL
progressors	NULL
[	NULL
12-16	NULL
]	NULL
.	NULL

This	NULL
altered	NULL
pattern	NULL
of	NULL
cytokine	NULL
induction	NULL
may	NULL
be	NULL
in	NULL
turn	NULL
related	NULL
to	NULL
increased	NULL
commitment	NULL
to	NULL
apoptosis	NULL
.	NULL

HIV-infected	NULL
subjects	NULL
commonly	NULL
display	NULL
altered	NULL
levels	NULL
and	NULL
function	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
1	NULL
[	NULL
17	NULL
]	NULL
,	NULL
involved	NULL
in	NULL
the	NULL
effector	NULL
function	NULL
of	NULL
one	NULL
of	NULL
the	NULL
main	NULL
classes	NULL
of	NULL
HIV-induced	NULL
cytokines	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
IFN	NULL
family	NULL
[	NULL
18,19	NULL
]	NULL
.	NULL

Additionally	NULL
,	NULL
IFN	NULL
regulatory	NULL
factor	NULL
(	NULL
IRF	NULL
)	NULL
-1	NULL
,	NULL
induced	NULL
by	NULL
many	NULL
HIV-1-driven	NULL
cytokines	NULL
,	NULL
is	NULL
able	NULL
to	NULL
up-regulate	NULL
IL-1B-converting	NULL
enzyme	NULL
(	NULL
ICE	NULL
)	NULL
,	NULL
also	NULL
known	NULL
as	NULL
caspase-1	NULL
,	NULL
that	NULL
can	NULL
be	NULL
involved	NULL
in	NULL
apoptosis	NULL
[	NULL
20	NULL
]	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
used	NULL
an	NULL
established	NULL
experimental	NULL
model	NULL
,	NULL
consisting	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
from	NULL
normal	NULL
donors	NULL
exposed	NULL
to	NULL
cells	NULL
infected	NULL
with	NULL
either	NULL
a	NULL
X4	NULL
(	NULL
IIIB	NULL
)	NULL
or	NULL
a	NULL
R5	NULL
(	NULL
Bal	NULL
)	NULL
HIV-1	NULL
strain	NULL
and	NULL
fixed	NULL
with	NULL
formaldehyde	NULL
[	NULL
10,12,16	NULL
]	NULL
.	NULL

In	NULL
this	NULL
system	NULL
we	NULL
analysed	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
activation	NULL
factors	NULL
such	NULL
as	NULL
STAT	NULL
1	NULL
and	NULL
IRF-1	NULL
together	NULL
with	NULL
the	NULL
commitment	NULL
to	NULL
apoptosis	NULL
,	NULL
exploring	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
HIV-induced	NULL
cytokines	NULL
in	NULL
these	NULL
phenomena	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
of	NULL
HIV-1-infected	NULL
fixed	NULL
cells	NULL
Lymphoblastoid	NULL
T	NULL
cells	NULL
,	NULL
uninfected	NULL
(	NULL
H9	NULL
)	NULL
or	NULL
chronically	NULL
infected	NULL
©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Induction	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
375	NULL
with	NULL
HIV-1	NULL
(	NULL
H9/IIIB	NULL
)	NULL
,	NULL
growing	NULL
in	NULL
logarithmic	NULL
phase	NULL
,	NULL
were	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
as	NULL
described	NULL
[	NULL
10	NULL
]	NULL
.	NULL

CD4	NULL
lymphocytes	NULL
infected	NULL
with	NULL
HIV-1	NULL
Bal	NULL
were	NULL
obtained	NULL
by	NULL
acute	NULL
infection	NULL
of	NULL
CD8-depleted	NULL
PBMC	NULL
with	NULL
the	NULL
monocytotropic	NULL
strain	NULL
HIV-1	NULL
BaL	NULL
,	NULL
i.e	NULL
.	NULL

CD8-depleted	NULL
PBMC	NULL
were	NULL
activated	NULL
with	NULL
phytohaemagglu-tinin	NULL
(	NULL
PHA	NULL
)	NULL
for	NULL
3	NULL
days	NULL
,	NULL
infected	NULL
with	NULL
HIV-1	NULL
Bal	NULL
strain	NULL
and	NULL
maintained	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
IL-2	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
for	NULL
10	NULL
days	NULL
,	NULL
then	NULL
fixed	NULL
as	NULL
above	NULL
.	NULL

A	NULL
parallel	NULL
culture	NULL
of	NULL
uninfected	NULL
CD4	NULL
lymphocytes	NULL
was	NULL
fixed	NULL
and	NULL
used	NULL
as	NULL
control	NULL
[	NULL
16	NULL
]	NULL
.	NULL

Experimental	NULL
design	NULL
PBMC	NULL
,	NULL
separated	NULL
by	NULL
Ficoll	NULL
gradient	NULL
centrifugation	NULL
from	NULL
buffy	NULL
coats	NULL
of	NULL
healthy	NULL
donors	NULL
,	NULL
were	NULL
exposed	NULL
to	NULL
HIV-1-infected	NULL
cells	NULL
fixed	NULL
as	NULL
above	NULL
,	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
30:1	NULL
,	NULL
unless	NULL
otherwise	NULL
specified	NULL
,	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
PBMC/ml	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

In	NULL
all	NULL
the	NULL
experiments	NULL
,	NULL
untreated	NULL
PBMC	NULL
and	NULL
PBMC	NULL
exposed	NULL
to	NULL
the	NULL
corresponding	NULL
uninfected	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

After	NULL
18	NULL
h	NULL
incubation	NULL
the	NULL
pellets	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
for	NULL
subsequent	NULL
analysis	NULL
.	NULL

Cytokine	NULL
neutralization	NULL
was	NULL
achieved	NULL
by	NULL
using	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
against	NULL
either	NULL
IFN-a	NULL
(	NULL
original	NULL
titre	NULL
:	NULL
5	NULL
x	NULL
10°	NULL
neutralization	NULL
units	NULL
(	NULL
NU	NULL
)	NULL
/m1I	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
original	NULL
titre	NULL
:	NULL
50	NULL
000	NULL
NU/m	NULL
!	NULL
)	NULL

,	NULL
obtained	NULL
in	NULL
our	NULL
laboratory	NULL
[	NULL
13	NULL
]	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
the	NULL
concentration	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-a	NULL
and	NULL
IFN-y	NULL
used	NULL
was	NULL
80	NULL
000	NULL
and	NULL
1000	NULL
NU	NULL
,	NULL
respectively	NULL
,	NULL
ie	NULL
.	NULL

5-10-fold	NULL
higher	NULL
than	NULL
that	NULL
required	NULL
to	NULL
neutralize	NULL
the	NULL
IFNs	NULL
present	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
PBMC	NULL
exposed	NULL
to	NULL
HIV-infected	NULL
cells	NULL
(	NULL
3000-30	NULL
000	NULL
U/ml	NULL
for	NULL
IFN-a	NULL
«	NULL
and	NULL
50-100	NULL
U/ml	NULL
for	NULL
IFN-y	NULL
)	NULL
[	NULL
10,12,13	NULL
]	NULL
.	NULL

TNF-a	NULL
neutralization	NULL
was	NULL
achieved	NULL
by	NULL
using	NULL
a	NULL
MoAb	NULL
(	NULL
clone	NULL
1825.121	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
with	NULL
a	NULL
neutralization	NULL
dose	NULL
(	NULL
ND	NULL
)	NULL
sp	NULL
of	NULL
0-1	NULL
mg/ml	NULL
for	NULL
1	NULL
ng/ml	NULL
of	NULL
TNF-a	NULL
.	NULL

This	NULL
antibody	NULL
was	NULL
used	NULL
at	NULL
10	NULL
mg/ml	NULL
,	NULL
i.e	NULL
.	NULL

at	NULL
least	NULL
five-fold	NULL
excess	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
amount	NULL
necessary	NULL
to	NULL
neutralize	NULL
the	NULL
TNF-	NULL
@	NULL
present	NULL
in	NULL
supernatants	NULL
of	NULL
PBMC	NULL
treated	NULL
with	NULL
gp120	NULL
of	NULL
IIIB	NULL
strain	NULL
(	NULL
3-3	NULL
+	NULL
0-8	NULL
ng/ml	NULL
)	NULL
[	NULL
2	NULL
]	NULL
.	NULL

SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
STAT	NULL
1	NULL
proteins	NULL
PBMC	NULL
from	NULL
the	NULL
various	NULL
experimental	NULL
conditions	NULL
were	NULL
collected	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
,	NULL
washed	NULL
and	NULL
lysed	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
under	NULL
agitation	NULL
in	NULL
RIPA	NULL
modified	NULL
buffer	NULL
(	NULL
Tris-HCI	NULL
50	NULL
mm	NULL
pH	NULL
7-4	NULL
,	NULL
NP-40	NULL
1	NULL
%	NULL
,	NULL
Na-deoxycolate	NULL
0-25	NULL
%	NULL
,	NULL
NaCl	NULL
150	NULL
mm	NULL
,	NULL
EDTA	NULL
1	NULL
mm	NULL
)	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
:	NULL
1	NULL
mg/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
mg/ml	NULL
leupeptin	NULL
and	NULL
1	NULL
mm	NULL
PMSF	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
14	NULL
000	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
in	NULL
clarified	NULL
lysates	NULL
was	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

About	NULL
30	NULL
ul	NULL
of	NULL
the	NULL
clarified	NULL
lysates	NULL
,	NULL
containing	NULL
30	NULL
mug	NULL
of	NULL
proteins	NULL
,	NULL
diluted	NULL
1:2	NULL
with	NULL
SDS	NULL
gel-loading	NULL
buffer	NULL
,	NULL
were	NULL
heated	NULL
to	NULL
100°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
loaded	NULL
on	NULL
8	NULL
%	NULL
acrylamide	NULL
gel	NULL
,	NULL
for	NULL
SDS-PAGE	NULL
.	NULL

Then	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
utilizing	NULL
a	NULL
semi-dry	NULL
electrophoretic	NULL
transfer	NULL
apparatus	NULL
(	NULL
BioRad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nitrocellulose	NULL
was	NULL
then	NULL
stained	NULL
with	NULL
Ponceau	NULL
red	NULL
solution	NULL
to	NULL
visualize	NULL
the	NULL
positions	NULL
of	NULL
standard	NULL
proteins	NULL
(	NULL
B-galactosidase	NULL
,	NULL
fructose	NULL
6-phosphate	NULL
kinase	NULL
and	NULL
pyruvate	NULL
kinase	NULL
;	NULL
Sigma	NULL
Aldrich	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

Immunoblot	NULL
was	NULL
performed	NULL
,	NULL
after	NULL
blocking	NULL
nitrocellulose	NULL
membrane	NULL
in	NULL
freshly	NULL
prepared	NULL
TBS	NULL
containing	NULL
3	NULL
%	NULL
dry	NULL
milk	NULL
,	NULL
by	NULL
using	NULL
anti-STAT	NULL
1	NULL
MoAb	NULL
(	NULL
anti-STAT	NULL
1a	NULL
and	NULL
B	NULL
(	NULL
p91/84	NULL
)	NULL
,	NULL
clone	NULL
E-23	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
primary	NULL
antibody	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
sequential	NULL
addition	NULL
of	NULL
anti-mouse	NULL
biotin	NULL
conjugate	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
streptavidin	NULL
AP	NULL
conjugate	NULL
(	NULL
Boehringer	NULL
Mann-heim	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
and	NULL
BCIP/NBT	NULL
fast	NULL
blue	NULL
(	NULL
Sigma	NULL
)	NULL
as	NULL
chromogen	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
conditions	NULL
for	NULL
IRF-1	NULL
,	NULL
ICE	NULL
and	NULL
B-actin	NULL
mRNA	NULL
detection	NULL
Pellets	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
PBMC	NULL
from	NULL
the	NULL
various	NULL
experimental	NULL
conditions	NULL
underwent	NULL
total	NULL
RNA	NULL
extraction	NULL
by	NULL
Trizol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
NY	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
in	NULL
the	NULL
indicated	NULL
cases	NULL
,	NULL
by	NULL
poly	NULL
A+	NULL
mRNA	NULL
purification	NULL
by	NULL
Oligotex	NULL
mRNA	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Hilden	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Reverse	NULL
transcription	NULL
of	NULL
3	NULL
Lg	NULL
of	NULL
total	NULL
RNA	NULL
extracted	NULL
was	NULL
performed	NULL
by	NULL
random	NULL
hexamer	NULL
method	NULL
with	NULL
M-MuLV	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Perkin	NULL
Elmer	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
42°C	NULL
and	NULL
then	NULL
15	NULL
min	NULL
at	NULL
65°C	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
two	NULL
different	NULL
pairs	NULL
of	NULL
primers	NULL
were	NULL
utilized	NULL
.	NULL

In	NULL
limiting	NULL
dilution	NULL
analysis	NULL
,	NULL
cDNA	NULL
was	NULL
serially	NULL
diluted	NULL
and	NULL
then	NULL
amplified	NULL
by	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
AAGCATGCTGCCAAGCATGG-CTGG	NULL
(	NULL
sense	NULL
primer	NULL
)	NULL
and	NULL
ATCAGGCAGAGTGGAGCTGTC	NULL
(	NULL
antisense	NULL
primer	NULL
)	NULL
.	NULL

The	NULL
conditions	NULL
of	NULL
amplification	NULL
were	NULL
:	NULL
28	NULL
cycles	NULL
(	NULL
95°C	NULL
for	NULL
35	NULL
s	NULL
,	NULL
55°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
15-min	NULL
period	NULL
at	NULL
72°C	NULL
;	NULL
the	NULL
size	NULL
of	NULL
the	NULL
resulting	NULL
amplicon	NULL
was	NULL
363	NULL
bp	NULL
[	NULL
21	NULL
]	NULL
.	NULL

In	NULL
the	NULL
other	NULL
experiments	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
primers	NULL
were	NULL
the	NULL
following	NULL
:	NULL
CCAGAGAAAAGAAAGAAAGTCG	NULL
(	NULL
sense	NULL
primer	NULL
,	NULL
11GF	NULL
)	NULL
and	NULL
CACATGGCGACAGTGCTGG	NULL
(	NULL
antisense	NULL
primer	NULL
,	NULL
12GF	NULL
)	NULL
.	NULL

Amplification	NULL
was	NULL
carried	NULL
out	NULL
performing	NULL
30	NULL
cycles	NULL
(	NULL
94°C	NULL
for	NULL
35	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
62°C	NULL
for	NULL
40	NULL
s	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
followed	NULL
by	NULL
15	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
resulting	NULL
amplicon	NULL
was	NULL
206	NULL
bp	NULL
[	NULL
22	NULL
]	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
ICE	NULL
mRNA	NULL
,	NULL
the	NULL
primers	NULL
were	NULL
:	NULL
GCTATTAAGAAAGCCCA	NULL
(	NULL
sense	NULL
primer	NULL
)	NULL
and	NULL
TCAGTGGTGGGCATCTG	NULL
(	NULL
antisense	NULL
primer	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
30	NULL
cycles	NULL
(	NULL
95°C	NULL
for	NULL
35	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
55°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
15-min	NULL
period	NULL
at	NULL
72°C	NULL
;	NULL
the	NULL
size	NULL
of	NULL
the	NULL
resulting	NULL
amplicon	NULL
was	NULL
221	NULL
bp	NULL
[	NULL
21	NULL
]	NULL
.	NULL

cDNA	NULL
was	NULL
also	NULL
subjected	NULL
to	NULL
amplification	NULL
for	NULL
a	NULL
housekeeping	NULL
gene	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
B-actin	NULL
as	NULL
described	NULL
[	NULL
23	NULL
]	NULL
,	NULL
both	NULL
to	NULL
establish	NULL
the	NULL
suitability	NULL
of	NULL
the	NULL
cDNA	NULL
to	NULL
be	NULL
amplified	NULL
,	NULL
and	NULL
to	NULL
verify	NULL
by	NULL
serial	NULL
dilution	NULL
analysis	NULL
the	NULL
equal	NULL
abundance	NULL
of	NULL
retrotranscribed	NULL
material	NULL
between	NULL
the	NULL
samples	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
were	NULL
analysed	NULL
by	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
visualized	NULL
by	NULL
UV	NULL
fluorescence	NULL
after	NULL
staining	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
to	NULL
evaluate	NULL
the	NULL
relative	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
obtained	NULL
in	NULL
limiting	NULL
dilution	NULL
analysis	NULL
of	NULL
ICE	NULL
mRNA	NULL
,	NULL
electrophoresis	NULL
gel	NULL
underwent	NULL
analysis	NULL
by	NULL
Kodak	NULL
Digital	NULL
Science	NULL
EDAS	NULL
120	NULL
System	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

For	NULL
calculation	NULL
,	NULL
the	NULL
arbitrary	NULL
value	NULL
of	NULL
1000	NULL
was	NULL
assigned	NULL
to	NULL
the	NULL
undiluted	NULL
sample	NULL
of	NULL
control	NULL
PBMC	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
possible	NULL
contamination	NULL
by	NULL
DNA	NULL
,	NULL
we	NULL
also	NULL
amplified	NULL
the	NULL
resulting	NULL
cDNA	NULL
samples	NULL
with	NULL
primers	NULL
specific	NULL
for	NULL
an	NULL
intron-containing	NULL
region	NULL
of	NULL
human	NULL
HLA-DR	NULL
as	NULL
described	NULL
[	NULL
24	NULL
]	NULL
.	NULL

By	NULL
this	NULL
method	NULL
,	NULL
all	NULL
RNA	NULL
samples	NULL
analysed	NULL
resulted	NULL
free	NULL
of	NULL
contaminating	NULL
cellular	NULL
DNA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
by	NULL
in	NULL
situ	NULL
TUNEL	NULL
reaction	NULL
Apoptotic	NULL
cell	NULL
death	NULL
was	NULL
visualized	NULL
at	NULL
single-cell	NULL
level	NULL
by	NULL
the	NULL
TdT-mediated	NULL
dUTP	NULL
nick	NULL
end	NULL
labelling	NULL
(	NULL
TUNEL	NULL
)	NULL
method	NULL
,	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

TUNEL	NULL
reaction	NULL
was	NULL
performed	NULL
on	NULL
samples	NULL
spotted	NULL
onto	NULL
slides	NULL
for	NULL
fluorescence	NULL
analysis	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
analysed	NULL
under	NULL
a	NULL
fluorescence	NULL
microscope	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
apoptotic	NULL
cells	NULL
were	NULL
detected	NULL
by	NULL
examining	NULL
for	NULL
each	NULL
sample	NULL
at	NULL
least	NULL
four	NULL
microscopy	NULL
fields	NULL
containing	NULL
almost	NULL
100	NULL
cells	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptosis	NULL
was	NULL
expressed	NULL
as	NULL
percentage	NULL
TUNEL	NULL
*	NULL
cells	NULL
.	NULL

Caspase-3	NULL
activity	NULL
determination	NULL
Measurement	NULL
of	NULL
caspase-3	NULL
protease	NULL
activity	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL
376	NULL
lysed	NULL
pellets	NULL
of	NULL
3	NULL
x	NULL
10°	NULL
PBMC	NULL
from	NULL
the	NULL
various	NULL
experimental	NULL
conditions	NULL
by	NULL
a	NULL
commercially	NULL
available	NULL
colourimetric	NULL
assay	NULL
(	NULL
Promega	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

As	NULL
positive	NULL
control	NULL
,	NULL
PBMC	NULL
were	NULL
exposed	NULL
to	NULL
apoptosis	NULL
inducers	NULL
such	NULL
as	NULL
M33	NULL
,	NULL
a	NULL
Fas	NULL
agonistic	NULL
MoAb	NULL
(	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
at	NULL
10	NULL
mg/ml	NULL
plus	NULL
PHA	NULL
at	NULL
1	NULL
mg/ml	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
also	NULL
conducted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
specific	NULL
pan-caspase	NULL
inhibitor	NULL
(	NULL
Z-VAD-FMK	NULL
)	NULL
included	NULL
in	NULL
the	NULL
kit	NULL
.	NULL

Statistical	NULL
analysis	NULL
Statistical	NULL
significance	NULL
of	NULL
the	NULL
observed	NULL
differences	NULL
was	NULL
evaluated	NULL
using	NULL
Student	NULL
's	NULL
t-test	NULL
on	NULL
mean	NULL
values	NULL
from	NULL
different	NULL
experiments	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

RESULTS	NULL
Stimulation	NULL
of	NULL
STAT	NULL
1	NULL
a	NULL
and	NULL
B	NULL
proteins	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
neutralizing	NULL
antibodies	NULL
to	NULL
IFNs	NULL
To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
exposure	NULL
to	NULL
bystander	NULL
HIV-infected	NULL
cells	NULL
on	NULL
the	NULL
levels	NULL
of	NULL
STAT	NULL
1	NULL
a	NULL
and	NULL
[	NULL
3	NULL
proteins	NULL
in	NULL
normal	NULL
PBMC	NULL
,	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
lysates	NULL
of	NULL
PBMC	NULL
co-cultivated	NULL
for	NULL
18	NULL
h	NULL
with	NULL
HIV-infected	NULL
or	NULL
non-infected	NULL
cells	NULL
.	NULL

As	NULL
positive	NULL
control	NULL
of	NULL
STAT	NULL
1	NULL
induction	NULL
,	NULL
PBMC	NULL
exposed	NULL
to	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
were	NULL
used	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

la	NULL
,	NULL
STAT	NULL
1	NULL
I.	NULL
Abbate	NULL
,	NULL
F.	NULL
Dianzani	NULL
&	NULL
M.	NULL
R.	NULL
Capobianchi	NULL
a	NULL
isoform	NULL
is	NULL
slightly	NULL
more	NULL
evident	NULL
than	NULL
the	NULL
3	NULL
isoform	NULL
in	NULL
unstimulated	NULL
PBMC	NULL
and	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
uninfected	NULL
CD4	NULL
and	NULL
H9	NULL
cells	NULL
We	NULL
could	NULL
not	NULL
discriminate	NULL
whether	NULL
differential	NULL
expression	NULL
,	NULL
or	NULL
differential	NULL
affinity	NULL
of	NULL
the	NULL
antibody	NULL
,	NULL
was	NULL
responsible	NULL
for	NULL
a	NULL
more	NULL
pronounced	NULL
visualization	NULL
of	NULL
the	NULL
larger	NULL
isoform	NULL
in	NULL
PBMC	NULL
.	NULL

However	NULL
,	NULL
when	NULL
analysing	NULL
PBMC	NULL
exposed	NULL
to	NULL
either	NULL
CD4/	NULL
Bal	NULL
.	NULL

or	NULL
H9/IIIB	NULL
cells	NULL
,	NULL
a	NULL
proportional	NULL
increase	NULL
of	NULL
both	NULL
isoforms	NULL
was	NULL
observed	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
a	NULL
proportional	NULL
increase	NULL
of	NULL
STAT	NULL
1	NULL
a	NULL
and	NULL
(	NULL
3	NULL
protein	NULL
levels	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
IFN-y-treated	NULL
PBMC	NULL
.	NULL

Induction	NULL
experiments	NULL
were	NULL
also	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
IFN-	NULL
and	NULL
IFN-y	NULL
,	NULL
known	NULL
to	NULL
be	NULL
able	NULL
to	NULL
up-regulate	NULL
these	NULL
proteins	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
indicate	NULL
that	NULL
up-regulation	NULL
of	NULL
STAT	NULL
1	NULL
proteins	NULL
is	NULL
abrogated	NULL
by	NULL
anti-IFN-a	NULL
,	NULL
but	NULL
not	NULL
by	NULL
anti-IFN-y	NULL
antibodies	NULL
,	NULL
suggesting	NULL
that	NULL
IFN-	NULL
is	NULL
the	NULL
main	NULL
cytokine	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
1	NULL
when	NULL
normal	NULL
PBMC	NULL
are	NULL
exposed	NULL
to	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

Up-regulation	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
levels	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
and	NULL
effect	NULL
of	NULL
neutralizing	NULL
antibodies	NULL
to	NULL
IFNs	NULL
and	NULL
TNF-a	NULL
To	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
exposure	NULL
to	NULL
bystander	NULL
HIV-1-infected	NULL
cells	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
IRF-1	NULL
and	NULL
ICE	NULL
,	NULL
we	NULL
measured	NULL
IRF-1	NULL
and	NULL
ICE	NULL
mRNA	NULL
levels	NULL
in	NULL
normal	NULL
PBMC	NULL
co-cultivated	NULL
with	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
used	NULL
for	NULL
STAT	NULL
1	NULL
experiments	NULL
,	NULL
by	NULL
limiting	NULL
dilution	NULL
reverse	NULL
transcriptase-polymerase	NULL
(	NULL
a	NULL
)	NULL
kD	NULL
-	NULL
\	NULL
20	NULL
STAT	NULL
la	NULL
~-	NULL
me	NULL
.	NULL

STAT	NULL
186	NULL
mae	NULL
«	NULL
jem	NULL
.	NULL

G/	NULL
_	NULL
75	NULL
«	NULL
&	NULL
c*	NULL
B	NULL
&	NULL
$	NULL
&	NULL
y	NULL
A	NULL
&	NULL
6	NULL
$	NULL
to	NULL
&	NULL
&	NULL
(	NULL
b	NULL
)	NULL
-	NULL
120	NULL
STAT	NULL
i	NULL
,	NULL
|	NULL
--	NULL
»	NULL
-	NULL
UDA	NULL
~~~	NULL
STAT	NULL
18	NULL
-	NULL
Gam	NULL
-	NULL
3	NULL
!	NULL

«	NULL
Gem	NULL
_	NULL
75	NULL
&	NULL
A	NULL
$	NULL
*	NULL
*	NULL
aA	NULL
*	NULL
«	NULL
*	NULL
$	NULL
C	NULL
C	NULL
y*	NULL
es	NULL
<	NULL
>	NULL
&	NULL
#	NULL
y	NULL
y	NULL
v	NULL
&	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
STAT	NULL
1	NULL
a	NULL
and	NULL
B	NULL
protein	NULL
expressed	NULL
by	NULL
normal	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
exposed	NULL
to	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
antibodies	NULL
to	NULL
IFNs	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Normal	NULL
PBMC	NULL
were	NULL
cultivated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
CTR	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cells	NULL
either	NULL
uninfected	NULL
(	NULL
CD4	NULL
and	NULL
H9	NULL
)	NULL
or	NULL
infected	NULL
with	NULL
HIV-1	NULL
(	NULL
CD4/BaL	NULL
and	NULL
H9/IIIB	NULL
)	NULL
,	NULL
fixed	NULL
as	NULL
described	NULL
[	NULL
16	NULL
]	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Normal	NULL
PBMC	NULL
,	NULL
stimulated	NULL
with	NULL
H9/IIIB-infected	NULL
cells	NULL
,	NULL
were	NULL
cultivated	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-a	NULL
and	NULL
IFN-y	NULL
(	NULL
singly	NULL
or	NULL
mixed	NULL
)	NULL
.	NULL

Unstimulated	NULL
PBMC	NULL
(	NULL
CTR	NULL
)	NULL
represented	NULL
baseline	NULL
expression	NULL
level	NULL
.	NULL

As	NULL
control	NULL
STAT	NULL
1	NULL
inducer	NULL
,	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
was	NULL
used	NULL
.	NULL

PBMC	NULL
were	NULL
collected	NULL
and	NULL
lysed	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
analysed	NULL
by	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membrane	NULL
and	NULL
stained	NULL
with	NULL
anti-STAT	NULL
1	NULL
a	NULL
and	NULL
B	NULL
MoAb	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL
Induction	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
,	NULL
and	NULL
underwent	NULL
RNA	NULL
extraction	NULL
and	NULL
retrotranscription	NULL
.	NULL

cDNA	NULL
was	NULL
then	NULL
serially	NULL
diluted	NULL
and	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Also	NULL
in	NULL
these	NULL
experiments	NULL
IFN-y	NULL
at	NULL
1000	NULL
U/ml	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
of	NULL
IRF-1	NULL
and	NULL
ICE	NULL
mRNA	NULL
induction	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2a	NULL
,	NULL
PBMC	NULL
co-cultivated	NULL
with	NULL
H9/IIIB	NULL
cells	NULL
showed	NULL
a	NULL
pronounced	NULL
increase	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
levels	NULL
,	NULL
comparable	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
IFN-y	NULL
.	NULL

Similar	NULL
induction	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
was	NULL
observed	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
cells	NULL
infected	NULL
with	NULL
HIV-1	NULL
Bal	NULL
,	NULL
whereas	NULL
no	NULL
induction	NULL
was	NULL
observed	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
uninfected	NULL
H9	NULL
and	NULL
CD4	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
PBMC	NULL
co-cultivated	NULL
with	NULL
H9/IIIB	NULL
,	NULL
a	NULL
slight	NULL
(	NULL
about	NULL
three-fold	NULL
)	NULL
increase	NULL
of	NULL
ICE	NULL
mRNA	NULL
levels	NULL
was	NULL
detected	NULL
,	NULL
when	NULL
applying	NULL
digital	NULL
analysis	NULL
to	NULL
the	NULL
electrophoresis	NULL
gel	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2b	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
involvement	NULL
of	NULL
HIV-induced	NULL
cytokines	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
IRF-1	NULL
expression	NULL
,	NULL
we	NULL
performed	NULL
induction	NULL
experiments	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
IFN-	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
,	NULL
that	NULL
are	NULL
able	NULL
to	NULL
up-regulate	NULL
this	NULL
factor	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2¢	NULL
)	NULL
indicate	NULL
that	NULL
IRF-1	NULL
mRNA	NULL
up-regulation	NULL
is	NULL
abrogated	NULL
by	NULL
{	NULL
a	NULL
}	NULL
IRE-1	NULL
B-actin	NULL
«	NULL
fmm	NULL
G40	NULL
bs	NULL
CTR	NULL
Ha/NB	NULL
M	NULL
(	NULL
c	NULL
)	NULL
IRF-1	NULL
_	NULL
tm	NULL
388	NULL
te	NULL
¢	NULL
Ao	NULL
.	NULL

«	NULL
$	NULL
w*	NULL
f	NULL
&	NULL
A	NULL
M	NULL
L	NULL
}	NULL
<	NULL
5	NULL
?	NULL

of	NULL
``	NULL
ﬁ	NULL
?	NULL

Q3	NULL
‘	NULL
§	NULL
$	NULL
,	NULL
$	NULL
§§L	NULL
iss	NULL
TF	NULL
v5	NULL
``	NULL
y	NULL
377	NULL
anti-IFN-a	NULL
antibodies	NULL
,	NULL
and	NULL
not	NULL
by	NULL
antibodies	NULL
against	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
these	NULL
experimental	NULL
conditions	NULL
,	NULL
IFN-a	NULL
is	NULL
the	NULL
main	NULL
cytokine	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
IRF-1	NULL
expression	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
and	NULL
effects	NULL
of	NULL
antibodies	NULL
neutralizing	NULL
IFNs	NULL
and	NULL
TNF-a	NULL
To	NULL
evaluate	NULL
the	NULL
possible	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
normal	NULL
PBMC	NULL
were	NULL
exposed	NULL
to	NULL
increasing	NULL
amounts	NULL
of	NULL
either	NULL
CD4/BaL	NULL
.	NULL

or	NULL
H9/IIIB	NULL
cells	NULL
.	NULL

Apoptotic	NULL
commitment	NULL
was	NULL
measured	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
by	NULL
in	NULL
site	NULL
TUNEL	NULL
reaction	NULL
,	NULL
which	NULL
detects	NULL
DNA	NULL
fragmentation	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
results	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
,	NULL
indicate	NULL
that	NULL
a	NULL
small	NULL
but	NULL
significant	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
dose-dependently	NULL
induced	NULL
in	NULL
normal	NULL
PBMC	NULL
exposed	NULL
to	NULL
cells	NULL
infected	NULL
with	NULL
either	NULL
HIV-1	NULL
Bal	NULL
.	NULL

or	NULL
IIIB	NULL
,	NULL
whereas	NULL
the	NULL
corresponding	NULL
uninfected	NULL
cells	NULL
were	NULL
ineffective	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
ICE	NULL
promoter	NULL
is	NULL
one	NULL
of	NULL
the	NULL
targets	NULL
of	NULL
IRF-1	NULL
transactivation	NULL
activity	NULL
,	NULL
and	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
H9/IIB-infected	NULL
cells	NULL
the	NULL
levels	NULL
of	NULL
ICE	NULL
mRNA	NULL
are	NULL
slightly	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
,	NULL
we	NULL
considered	NULL
(	NULL
b	NULL
)	NULL
TR	NULL
1000	NULL
#	NULL
.	NULL

-¥-	NULL
CT	NULL
t	NULL
``	NULL
--	NULL
..____	NULL
&	NULL
.	NULL

“	NULL
Ha-Lu	NULL
“	NULL
!	NULL

-~	NULL
i\	NULL
--	NULL
HIB	NULL
``	NULL
x	NULL
£	NULL
100	NULL
|	NULL
2	NULL
a	NULL
~	NULL
&	NULL
®	NULL
5	NULL
=	NULL
8	NULL
=	NULL
&	NULL
®	NULL
5	NULL
5	NULL
*j	NULL
a	NULL
§	NULL
,	NULL
A	NULL
2	NULL
I	NULL
ol	NULL
\	NULL
il	NULL
9	NULL
I	NULL
W	NULL
&	NULL
\	NULL
\	NULL
1	NULL
041	NULL
*	NULL
#	NULL
10	NULL
100	NULL
Reciprocal	NULL
of	NULL
dilution	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

IFN	NULL
regulatory	NULL
factor	NULL
(	NULL
IRF	NULL
)	NULL
-1	NULL
and	NULL
IL-1B-converting	NULL
enzyme	NULL
(	NULL
ICE	NULL
)	NULL
mRNA	NULL
levels	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
exposed	NULL
to	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-	NULL
@	NULL
,	NULL
IFN-y	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Normal	NULL
PBMC	NULL
cultivated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
CTR	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
(	NULL
H9/IIIB	NULL
)	NULL
were	NULL
collected	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
.	NULL

As	NULL
control	NULL
IRF-1	NULL
inducer	NULL
,	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Extraction	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
retrotranscription	NULL
were	NULL
performed	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

For	NULL
limiting	NULL
dilution	NULL
analysis	NULL
,	NULL
five	NULL
serial	NULL
five-fold	NULL
dilutions	NULL
of	NULL
the	NULL
retrotranscribed	NULL
samples	NULL
underwent	NULL
polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
IRF-1	NULL
(	NULL
first	NULL
dilution	NULL
corresponding	NULL
to	NULL
RNA	NULL
extracted	NULL
from	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
and	NULL
for	NULL
B-actin	NULL
(	NULL
first	NULL
dilution	NULL
corresponding	NULL
to	NULL
RNA	NULL
extracted	NULL
from	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Retrotranscribed	NULL
samples	NULL
from	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
as	NULL
in	NULL
(	NULL
a	NULL
)	NULL
underwent	NULL
limiting	NULL
dilution	NULL
analysis	NULL
for	NULL
ICE	NULL
mRNA	NULL
.	NULL

The	NULL
gel	NULL
underwent	NULL
digital	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
expressed	NULL
as	NULL
relative	NULL
intensity	NULL
of	NULL
fluorescence	NULL
,	NULL
assuming	NULL
the	NULL
arbitrary	NULL
value	NULL
of	NULL
1000	NULL
to	NULL
the	NULL
undiluted	NULL
sample	NULL
from	NULL
control	NULL
PBMC	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
B-actin	NULL
values	NULL
were	NULL
superimposable	NULL
for	NULL
the	NULL
three	NULL
experimental	NULL
conditions	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Normal	NULL
PBMC	NULL
,	NULL
stimulated	NULL
with	NULL
H9/IIIB	NULL
infected	NULL
cells	NULL
,	NULL
were	NULL
cultivated	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
singularly	NULL
or	NULL
mixed	NULL
)	NULL
.	NULL

Unstimulated	NULL
PBMC	NULL
(	NULL
CTR	NULL
)	NULL
represented	NULL
baseline	NULL
expression	NULL
level	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
after	NULL
18	NULL
h	NULL
incubation	NULL
.	NULL

As	NULL
control	NULL
IRF-1	NULL
inducer	NULL
,	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
!	NULL
)	NULL

was	NULL
used	NULL
.	NULL

Amounts	NULL
of	NULL
purified	NULL
poly	NULL
A+	NULL
mRNA	NULL
corresponding	NULL
to	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
for	NULL
each	NULL
sample	NULL
were	NULL
retrotranscribed	NULL
,	NULL
and	NULL
amplified	NULL
using	NULL
the	NULL
primers	NULL
for	NULL
IRF-1	NULL
(	NULL
11GF	NULL
and	NULL
12GF	NULL
)	NULL
.The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL
378	NULL
I.	NULL
Abbate	NULL
,	NULL
F.	NULL
Dianzani	NULL
&	NULL
M.	NULL
R.	NULL
Capobianchi	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
caspase	NULL
pathway	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
our	NULL
experimental	NULL
system	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
proteolytic	NULL
activity	NULL
of	NULL
one	NULL
of	NULL
the	NULL
effector	NULL
caspases	NULL
(	NULL
i.e	NULL
.	NULL

caspase-3	NULL
)	NULL
in	NULL
lysates	NULL
of	NULL
PBMC	NULL
co-cultivated	NULL
with	NULL
H9/IIIB	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
control	NULL
of	NULL
caspase-3	NULL
activity	NULL
induction	NULL
,	NULL
we	NULL
used	NULL
a	NULL
Fas	NULL
agonistic	NULL
MoAb	NULL
(	NULL
M33	NULL
)	NULL
together	NULL
with	NULL
PHA	NULL
stimulation	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
H9/IMIB	NULL
cells	NULL
do	NULL
not	NULL
induce	NULL
caspase-3	NULL
activity	NULL
,	NULL
whereas	NULL
anti-Fas	NULL
antibody	NULL
plus	NULL
PHA	NULL
increase	NULL
this	NULL
activity	NULL
in	NULL
PBMC	NULL
,	NULL
and	NULL
this	NULL
enhancement	NULL
is	NULL
almost	NULL
completely	NULL
abrogated	NULL
(	NULL
88	NULL
+	NULL
10	NULL
%	NULL
inhibition	NULL
)	NULL
by	NULL
the	NULL
caspase	NULL
inhibitor	NULL
z-VAD-FMK	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
soluble	NULL
factors	NULL
,	NULL
we	NULL
used	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
some	NULL
of	NULL
the	NULL
cytokines	NULL
induced	NULL
by	NULL
HIV-1	NULL
and	NULL
possibly	NULL
involved	NULL
in	NULL
apoptosis	NULL
,	NULL
namely	NULL
IFN-	NULL
,	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
.	NULL

In	NULL
situ	NULL
TUNEL	NULL
reaction	NULL
revealed	NULL
that	NULL
,	NULL
among	NULL
the	NULL
antibodies	NULL
tested	NULL
,	NULL
anti-TNF-	NULL
@	NULL
was	NULL
the	NULL
most	NULL
effective	NULL
in	NULL
reducing	NULL
the	NULL
extent	NULL
of	NULL
apoptosis	NULL
induced	NULL
by	NULL
HIV-infected	NULL
cells	NULL
.	NULL

A	NULL
significant	NULL
,	NULL
but	NULL
less	NULL
pronounced	NULL
,	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
antibodies	NULL
to	NULL
IFN-y	NULL
were	NULL
used	NULL
,	NULL
whereas	NULL
antibodies	NULL
to	NULL
IFN-	NULL
were	NULL
completely	NULL
ineffective	NULL
.	NULL

The	NULL
mixture	NULL
of	NULL
the	NULL
all	NULL
three	NULL
antibodies	NULL
was	NULL
the	NULL
most	NULL
effective	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
we	NULL
show	NULL
that	NULL
exposure	NULL
to	NULL
HIV-1-infected	NULL
cells	NULL
may	NULL
trigger	NULL
,	NULL
in	NULL
normal	NULL
PBMC	NULL
,	NULL
signal	NULL
transduction	NULL
pathways	NULL
related	NULL
mainly	NULL
to	NULL
IFN-a	NULL
effector	NULL
functions	NULL
.	NULL

Particularly	NULL
,	NULL
we	NULL
observed	NULL
an	NULL
enhanced	NULL
level	NULL
of	NULL
STAT	NULL
1	NULL
proteins	NULL
and	NULL
an	NULL
increased	NULL
amount	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
in	NULL
PBMC	NULL
from	NULL
HIV-1-infected	NULL
subjects	NULL
in	NULL
all	NULL
stages	NULL
of	NULL
the	NULL
disease	NULL
there	NULL
is	NULL
a	NULL
decrease	NULL
of	NULL
STAT5A	NULL
,	NULL
STAT5B	NULL
,	NULL
and	NULL
STAT	NULL
1	NULL
a	NULL
protein	NULL
expression	NULL
,	NULL
probably	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
chronic	NULL
activation	NULL
of	NULL
certain	NULL
signal	NULL
transduction	NULL
patterns	NULL
by	NULL
dysregulated	NULL
cytokine	NULL
production	NULL
,	NULL
that	NULL
can	NULL
be	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
exhausted	NULL
or	NULL
down-modulated	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
vitro	NULL
infection	NULL
of	NULL
normal	NULL
PBMC	NULL
determines	NULL
a	NULL
selective	NULL
decrease	NULL
in	NULL
STATS5B	NULL
protein	NULL
levels	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
viral	NULL
strain	NULL
[	NULL
17	NULL
]	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
cells	NULL
infected	NULL
with	NULL
either	NULL
a	NULL
T-tropic	NULL
(	NULL
X4	NULL
)	NULL
or	NULL
monocytotropic	NULL
(	NULL
R5	NULL
)	NULL
HIV-1	NULL
strain	NULL
co-induce	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
including	NULL
IFN-a	NULL
and	NULL
IFN-y	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
an	NULL
enhanced	NULL
antiviral	NULL
activity	NULL
referred	NULL
to	NULL
as	NULL
acid-labile	NULL
IFN-	NULL
[	NULL
12,13	NULL
]	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
report	NULL
that	NULL
IFN-a	NULL
induced	NULL
by	NULL
HIV-1	NULL
is	NULL
mainly	NULL
responsible	NULL
for	NULL
the	NULL
enhanced	NULL
in	NULL
vitro	NULL
levels	NULL
of	NULL
STAT	NULL
1	NULL
a	NULL
and	NULL
B	NULL
proteins	NULL
in	NULL
normal	NULL
PBMC	NULL
.	NULL

This	NULL
phenomenon	NULL
may	NULL
be	NULL
related	NULL
to	NULL
increased	NULL
amounts	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
transcripts	NULL
,	NULL
that	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
seem	NULL
to	NULL
be	NULL
subsequent	NULL
to	NULL
IFN-a	NULL
induction	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
experiments	NULL
performed	NULL
with	NULL
anti-cytokine	NULL
antibodies	NULL
.	NULL

Even	NULL
if	NULL
other	NULL
mechanisms	NULL
,	NULL
such	NULL
as	NULL
TNF-mediated	NULL
NF-KB	NULL
activation	NULL
,	NULL
may	NULL
induce	NULL
activation	NULL
of	NULL
IRF-1	NULL
gene	NULL
expression	NULL
[	NULL
22,25	NULL
]	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
abrogation	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
increase	NULL
by	NULL
anti-TNF-	NULL
@	NULL
.	NULL

These	NULL
data	NULL
do	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
delineate	NULL
whether	NULL
increased	NULL
IRF-1	NULL
mRNA	NULL
levels	NULL
are	NULL
due	NULL
to	NULL
enhanced	NULL
transcription	NULL
or	NULL
to	NULL
decreased	NULL
degradation	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
that	NULL
HIV-1	NULL
,	NULL
per	NULL
se	NULL
,	NULL
can	NULL
directly	NULL
cause	NULL
an	NULL
additional	NULL
IRF-1	NULL
mRNA	NULL
induction	NULL
,	NULL
as	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
human	NULL
epithelial	NULL
cells	NULL
infected	NULL
with	NULL
respiratory	NULL
syncytial	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
[	NULL
21	NULL
]	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
also	NULL
explored	NULL
the	NULL
possibility	NULL
that	NULL
exposure	NULL
to	NULL
HIV-infected	NULL
cells	NULL
can	NULL
induce	NULL
apoptosis	NULL
in	NULL
normal	NULL
PBMC	NULL
.	NULL

We	NULL
first	NULL
showed	NULL
that	NULL
in	NULL
co-cultures	NULL
of	NULL
PBMC	NULL
with	NULL
cells	NULL
infected	NULL
with	NULL
either	NULL
X4	NULL
or	NULL
R5	NULL
strains	NULL
of	NULL
HIV-1	NULL
there	NULL
is	NULL
a	NULL
dose-dependent	NULL
increase	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptosis	NULL
observed	NULL
in	NULL
our	NULL
experimental	NULL
system	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
showed	NULL
by	NULL
others	NULL
using	NULL
HIV-infected	NULL
cells	NULL
[	NULL
26	NULL
]	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
gp120	NULL
,	NULL
exposed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
HIV-infected	NULL
cells	NULL
,	NULL
is	NULL
the	NULL
main	NULL
protein	NULL
responsible	NULL
for	NULL
the	NULL
triggering	NULL
of	NULL
apoptosis	NULL
in	NULL
target	NULL
cells	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
cross-linking	NULL
of	NULL
CD4	NULL
molecules	NULL
by	NULL
gp120	NULL
leads	NULL
to	NULL
apoptotic	NULL
death	NULL
of	NULL
lymphocytes	NULL
[	NULL
27	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
previous	NULL
experiments	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
,	NULL
similarly	NULL
to	NULL
HIV-infected	NULL
fixed	NULL
cells	NULL
,	NULL
soluble	NULL
recombinant	NULL
gp120	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
PBMC	NULL
to	NULL
undergo	NULL
apoptosis	NULL
[	NULL
28	NULL
]	NULL
.	NULL

Recently	NULL
it	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
that	NULL
chemokine	NULL
receptors	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
apoptosis	NULL
induction	NULL
by	NULL
HIV-1	NULL
through	NULL
membrane	NULL
mechanisms	NULL
[	NULL
11,29	NULL
]	NULL
.	NULL

In	NULL
this	NULL
view	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
X4	NULL
strains	NULL
and	NULL
SDF-1	NULL
are	NULL
more	NULL
effective	NULL
than	NULL
R5	NULL
strains	NULL
and	NULL
B-chemokines	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
[	NULL
30	NULL
]	NULL
,	NULL
but	NULL
it	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
the	NULL
case	NULL
in	NULL
our	NULL
conditions	NULL
,	NULL
since	NULL
a	NULL
similar	NULL
extent	NULL
and	NULL
dose-dependence	NULL
of	NULL
apoptosis	NULL
was	NULL
observed	NULL
when	NULL
using	NULL
a	NULL
R5	NULL
compared	NULL
with	NULL
a	NULL
X4	NULL
strain	NULL
.	NULL

We	NULL
explored	NULL
the	NULL
possibility	NULL
that	NULL
apoptosis	NULL
induction	NULL
by	NULL
HIV-1	NULL
may	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
an	NULL
increased	NULL
secretion	NULL
of	NULL
soluble	NULL
pro-apoptotic	NULL
mediators	NULL
,	NULL
such	NULL
as	NULL
TNF-a	NULL
and	NULL
IFNs	NULL
that	NULL
are	NULL
secreted	NULL
by	NULL
PBMC	NULL
in	NULL
response	NULL
to	NULL
either	NULL
HIV-1	NULL
Bal	NULL
.	NULL

or	NULL
IIIB	NULL
(	NULL
[	NULL
16	NULL
]	NULL
and	NULL
our	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
antibodies	NULL
directed	NULL
to	NULL
TNF-a	NULL
significantly	NULL
inhibit	NULL
apoptosis	NULL
induction	NULL
by	NULL
HIV-infected	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
abrogation	NULL
is	NULL
less	NULL
pronounced	NULL
with	NULL
antibodies	NULL
to	NULL
IFN-y	NULL
,	NULL
and	NULL
is	NULL
absent	NULL
with	NULL
antibodies	NULL
to	NULL
IFN-a	NULL
.	NULL

This	NULL
means	NULL
that	NULL
TNF-a	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
IFN-y	NULL
,	NULL
are	NULL
the	NULL
main	NULL
cytokines	NULL
responsible	NULL
for	NULL
apoptosis	NULL
after	NULL
18	NULL
h	NULL
exposure	NULL
to	NULL
HIV-infected	NULL
cells	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
observed	NULL
that	NULL
TNF-a	NULL
is	NULL
induced	NULL
in	NULL
PBMC	NULL
cultures	NULL
with	NULL
kinetics	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
IFN-a	NULL
,	NULL
reaching	NULL
a	NULL
plateau	NULL
after	NULL
1	NULL
day	NULL
of	NULL
stimulation	NULL
with	NULL
either	NULL
gp120	NULL
or	NULL
HIV-infected	NULL
cells	NULL
,	NULL
whereas	NULL
IFN-y	NULL
,	NULL
although	NULL
detectable	NULL
at	NULL
day	NULL
1	NULL
of	NULL
induction	NULL
,	NULL
is	NULL
released	NULL
with	NULL
a	NULL
much	NULL
slower	NULL
kinetics	NULL
,	NULL
reaching	NULL
peak	NULL
values	NULL
3	NULL
days	NULL
later	NULL
[	NULL
13	NULL
]	NULL
.	NULL

TNF-mediated	NULL
apoptosis	NULL
in	NULL
HIV-1	NULL
infection	NULL
has	NULL
been	NULL
well	NULL
documented	NULL
in	NULL
the	NULL
past	NULL
years	NULL
,	NULL
also	NULL
in	NULL
the	NULL
CD8	NULL
compartment	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
gp120	NULL
is	NULL
able	NULL
to	NULL
up-regulate	NULL
membrane	NULL
TNF-a	NULL
on	NULL
macrophages	NULL
and	NULL
TNF-a	NULL
receptors	NULL
on	NULL
CDS	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
increased	NULL
apoptosis	NULL
of	NULL
these	NULL
cells	NULL
[	NULL
31	NULL
]	NULL
.	NULL

It	NULL
should	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
TNF-a	NULL
may	NULL
induce	NULL
cell	NULL
apoptosis	NULL
by	NULL
several	NULL
mechanisms	NULL
,	NULL
which	NULL
can	NULL
be	NULL
partially	NULL
related	NULL
or	NULL
not	NULL
to	NULL
the	NULL
caspase	NULL
cascade	NULL
(	NULL
i.e	NULL
.	NULL

sphingomyelinase/ceramide	NULL
pathway	NULL
)	NULL
[	NULL
32,33	NULL
]	NULL
.	NULL

However	NULL
,	NULL
although	NULL
we	NULL
have	NULL
observed	NULL
a	NULL
small	NULL
increase	NULL
of	NULL
ICE	NULL
mRNA	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
HIV-infected	NULL
cells	NULL
,	NULL
concomitant	NULL
with	NULL
IRF-1	NULL
mRNA	NULL
induction	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
enhanced	NULL
proteolytic	NULL
activity	NULL
attributable	NULL
to	NULL
one	NULL
of	NULL
the	NULL
later	NULL
proteases	NULL
in	NULL
the	NULL
caspase	NULL
cascade	NULL
(	NULL
i.e	NULL
.	NULL

caspase-3	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
DNA	NULL
fragmentation	NULL
in	NULL
PBMC	NULL
stimulated	NULL
with	NULL
HIV-infected	NULL
cells	NULL
could	NULL
involve	NULL
effector	NULL
mechanisms	NULL
,	NULL
not	NULL
necessarily	NULL
involving	NULL
the	NULL
entire	NULL
caspase	NULL
cascade	NULL
.	NULL

There	NULL
is	NULL
substantial	NULL
evidence	NULL
that	NULL
anti-tumour	NULL
effects	NULL
of	NULL
the	NULL
IFNs	NULL
are	NULL
at	NULL
least	NULL
in	NULL
part	NULL
mediated	NULL
by	NULL
STAT	NULL
1	NULL
protein	NULL
activation	NULL
and	NULL
IRF-1	NULL
expression	NULL
,	NULL
that	NULL
can	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
induce	NULL
tumour	NULL
cell	NULL
apoptosis	NULL
[	NULL
34,35	NULL
]	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
two	NULL
IFN	NULL
types	NULL
are	NULL
reported	NULL
to	NULL
play	NULL
different	NULL
roles	NULL
in	NULL
apoptosis	NULL
induction	NULL
.	NULL

Several	NULL
data	NULL
showed	NULL
that	NULL
IFN-y	NULL
exerts	NULL
a	NULL
promoting	NULL
activity	NULL
in	NULL
the	NULL
apoptosis	NULL
of	NULL
leucocytes	NULL
,	NULL
mainly	NULL
through	NULL
the	NULL
up-regulation	NULL
of	NULL
Fas/FasL	NULL
molecules	NULL
,	NULL
whereas	NULL
IFN-	NULL
may	NULL
protect	NULL
activated	NULL
T	NULL
cells	NULL
from	NULL
apoptotic	NULL
death	NULL
[	NULL
36-38	NULL
]	NULL
.	NULL

Accordingly	NULL
,	NULL
in	NULL
our	NULL
experimental	NULL
system	NULL
antibodies	NULL
to	NULL
IFN-y	NULL
,	NULL
and	NULL
not	NULL
to	NULL
IFN-	NULL
«	NULL
a	NULL
,	NULL
inhibit	NULL
apoptosis	NULL
induction	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

Our	NULL
findings	NULL
may	NULL
have	NULL
possible	NULL
physiological	NULL
relevance	NULL
,	NULL
in	NULL
view	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
altered	NULL
levels	NULL
and	NULL
function	NULL
of	NULL
signal	NULL
©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL
Induction	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
apoptosis	NULL
by	NULL
HIV-1-infected	NULL
cells	NULL
379	NULL
(	NULL
a	NULL
)	NULL
%	NULL
%	NULL
4	NULL
|-	NULL
hi	NULL
%	NULL
,	NULL
’	NULL
5	NULL
(	NULL
b	NULL
)	NULL
€	NULL
*	NULL
10	NULL
8	NULL
5	NULL
3	NULL
8	NULL
o	NULL
8	NULL
F	NULL
a	NULL
2	NULL
6	NULL
0	NULL
o	NULL
.5	NULL
8	NULL
o	NULL
a	NULL
©	NULL
o	NULL
&	NULL
a	NULL
2	NULL
a	NULL
#	NULL
0	NULL
4	NULL
0	NULL
2	NULL
0	NULL
o_	NULL
2	NULL
1	NULL
I	NULL
I	NULL
I	NULL
o	NULL
100	NULL
200	NULL
300	NULL
Inducer	NULL
(	NULL
cells/ml	NULL
x	NULL
1000	NULL
)	NULL
Iliii	NULL
H9/IB	NULL
_	NULL
Anti-IFN-	NULL
«	NULL
@	NULL
Anti-IFN-y	NULL
Anti-TNF-	NULL
«	NULL
Antibody	NULL
mix	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
exposed	NULL
to	NULL
HIV-l-infected	NULL
cells	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-a	NULL
,	NULL
IFN-y	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Normal	NULL
PBMC	NULL
were	NULL
exposed	NULL
to	NULL
increasing	NULL
amounts	NULL
of	NULL
HIV-1-infected	NULL
cells	NULL
(	NULL
either	NULL
CD4/BaL	NULL
(	NULL
)	NULL
or	NULL
H9/IIIB	NULL
(	NULL
@	NULL
)	NULL
)	NULL
for	NULL
18	NULL
h.	NULL
Detection	NULL
of	NULL
apoptosis	NULL
was	NULL
performed	NULL
by	NULL
in	NULL
site	NULL
TUNEL	NULL
reaction	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
control	NULL
values	NULL
(	NULL
mean	NULL
*s.e.m	NULL
.	NULL

over	NULL
three	NULL
independent	NULL
experiments	NULL
)	NULL
of	NULL
apoptosis	NULL
detected	NULL
by	NULL
immunofluorescence	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
apoptotic	NULL
cells	NULL
in	NULL
control	NULL
PBMC	NULL
cultures	NULL
or	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
uninfected	NULL
cells	NULL
ranged	NULL
from	NULL
1-65	NULL
%	NULL
to	NULL
2:38	NULL
%	NULL
in	NULL
the	NULL
various	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0-05	NULL
;	NULL
**P	NULL
<	NULL
0-001	NULL
versus	NULL
control	NULL
in	NULL
Student	NULL
's	NULL
t-test	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Apoptosis	NULL
in	NULL
PBMC	NULL
stimulated	NULL
with	NULL
H9/IIIB	NULL
,	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
to	NULL
IFN-a	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
singly	NULL
or	NULL
mixed	NULL
)	NULL
.	NULL

Unstimulated	NULL
PBMC	NULL
(	NULL
CTR	NULL
)	NULL
represent	NULL
baseline	NULL
apoptosis	NULL
levels	NULL
.	NULL

After	NULL
18	NULL
h	NULL
incubation	NULL
,	NULL
cells	NULL
underwent	NULL
in	NULL
sity	NULL
TUNEL	NULL
reaction	NULL
.	NULL

Data	NULL
represent	NULL
mean	NULL
percentage	NULL
values	NULL
*s.e.m	NULL
.	NULL

over	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Statistical	NULL
significance	NULL
:	NULL
H9/IIB	NULL
versus	NULL
CTR	NULL
,	NULL
P	NULL
=	NULL
0-001	NULL
;	NULL
anti-IFN-y	NULL
versus	NULL
H9/IIIB	NULL
,	NULL
P	NULL
=	NULL
0-036	NULL
;	NULL
anti-TNF-	NULL
«	NULL
versus	NULL
H9/IIIB	NULL
,	NULL
P	NULL
=	NULL
0-003	NULL
;	NULL
and	NULL
antibody	NULL
mixture	NULL
versus	NULL
H9/IIIB	NULL
,	NULL
P	NULL
=	NULL
0-006	NULL
,	NULL
Student	NULL
's	NULL
test	NULL
.	NULL

transduction	NULL
mediators	NULL
(	NULL
such	NULL
as	NULL
STAT	NULL
proteins	NULL
)	NULL
are	NULL
commonly	NULL
observed	NULL
in	NULL
HIV-infected	NULL
patients	NULL
,	NULL
concomitantly	NULL
with	NULL
chronic	NULL
stimulation	NULL
of	NULL
cytokine	NULL
production	NULL
and	NULL
increased	NULL
commitment	NULL
to	NULL
apoptosis	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
these	NULL
phenomena	NULL
can	NULL
be	NULL
indirectly	NULL
triggered	NULL
in	NULL
uninfected	NULL
PBMC	NULL
by	NULL
bystander	NULL
infected	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
overall	NULL
effect	NULL
of	NULL
HIV-infected	NULL
cells	NULL
on	NULL
apoptosis	NULL
induction	NULL
in	NULL
PBMC	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
balance	NULL
of	NULL
different	NULL
cytokines	NULL
which	NULL
possess	NULL
pro-	NULL
or	NULL
anti-apoptotic	NULL
activities	NULL
.	NULL

Additional	NULL
studies	NULL
may	NULL
be	NULL
needed	NULL
to	NULL
better	NULL
elucidate	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
determining	NULL
lymphocyte	NULL
activation	NULL
and	NULL
apoptosis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
Ministero	NULL
della	NULL
Sanita	NULL
,	NULL
'Fondi	NULL
AIDS	NULL
'	NULL
,	NULL
to	NULL
M.R.C	NULL
.	NULL

and	NULL
to	NULL
F.D	NULL
.	NULL

,	NULL
and	NULL
from	NULL
'Fondi	NULL
Ricerca	NULL
Corrente®	NULL
to	NULL
``	NULL
L.	NULL
Spallanzani	NULL
'	NULL
IRCCS	NULL
.	NULL

REFERENCES	NULL
1	NULL
Bentwich	NULL
Z	NULL
,	NULL
Kalinkovich	NULL
A	NULL
,	NULL
Weisman	NULL
Z	NULL
,	NULL
Grossman	NULL
Z	NULL
.	NULL

Immune	NULL
activation	NULL
in	NULL
the	NULL
context	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
1998	NULL
;	NULL
111:1-2	NULL
.	NULL

2	NULL
Capobianchi	NULL
MR	NULL
.	NULL

Induction	NULL
of	NULL
lymphomonocyte	NULL
activation	NULL
by	NULL
HIV-1	NULL
glycoprotein	NULL
gp120	NULL
.	NULL

Possible	NULL
role	NULL
in	NULL
AIDS	NULL
pathogenesis	NULL
.	NULL

J	NULL
Biol	NULL
Regulators	NULL
Homeostatic	NULL
Agents	NULL
1996	NULL
;	NULL
10:83-91	NULL
.	NULL

3	NULL
Hellerstein	NULL
M	NULL
,	NULL
Handley	NULL
MB	NULL
,	NULL
Cesar	NULL
D	NULL
et	NULL
al	NULL
.	NULL

Directly	NULL
measured	NULL
kinetics	NULL
of	NULL
circulating	NULL
T	NULL
lymphocytes	NULL
in	NULL
normal	NULL
and	NULL
HIV-1-infected	NULL
humans	NULL
.	NULL

Nature	NULL
Med	NULL
1999	NULL
;	NULL
5:83-89	NULL
.	NULL

4	NULL
Kestens	NULL
L	NULL
,	NULL
Vanham	NULL
G	NULL
,	NULL
Vereecken	NULL
C	NULL
et	NULL
al	NULL
.	NULL

Selective	NULL
increase	NULL
of	NULL
activation	NULL
antigens	NULL
HLA-DR	NULL
and	NULL
CD38	NULL
on	NULL
CD4+CD4SRO+	NULL
T	NULL
lymphocytes	NULL
during	NULL
HIV-1	NULL
infection	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
1994	NULL
;	NULL
95:436-41	NULL
.	NULL

5	NULL
Liu	NULL
Z	NULL
,	NULL
Cumberland	NULL
WG	NULL
,	NULL
Hultin	NULL
LE	NULL
,	NULL
Prince	NULL
HE	NULL
,	NULL
Detels	NULL
R	NULL
,	NULL
Giorgi	NULL
JV	NULL
.	NULL

Elevated	NULL
CD38	NULL
antigen	NULL
expression	NULL
on	NULL
CD8+	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
stronger	NULL
marker	NULL
for	NULL
the	NULL
risk	NULL
of	NULL
chronic	NULL
HIV	NULL
disease	NULL
progression	NULL
to	NULL
AIDS	NULL
and	NULL
death	NULL
in	NULL
the	NULL
Multicenter	NULL
AIDS	NULL
Cohort	NULL
Study	NULL
than	NULL
CD4+	NULL
cell	NULL
count	NULL
,	NULL
soluble	NULL
immune	NULL
activation	NULL
markers	NULL
,	NULL
or	NULL
combination	NULL
of	NULL
HLA-DR	NULL
and	NULL
CD38	NULL
expression	NULL
.	NULL

J	NULL
Acquir	NULL
Immune	NULL
Defic	NULL
Synd	NULL
Hum	NULL
Retrovir	NULL
1997	NULL
;	NULL
16:83-92	NULL
.	NULL

6	NULL
Auewarakul	NULL
P	NULL
,	NULL
Sangsiriwut	NULL
K	NULL
,	NULL
Pattanapanyasat	NULL
K	NULL
,	NULL
Wasi	NULL
C.	NULL
Increase	NULL
in	NULL
activated	NULL
CD4+	NULL
lymphocytes	NULL
with	NULL
CCRS	NULL
and	NULL
CXCR4	NULL
in	NULL
HIV	NULL
type	NULL
1-infected	NULL
persons	NULL
.	NULL

AIDS	NULL
Res	NULL
Hum	NULL
Retrovir	NULL
1999	NULL
;	NULL
15:1403-4	NULL
.	NULL

7	NULL
Rothen	NULL
M	NULL
,	NULL
Gratzl	NULL
$	NULL
,	NULL
Hirsch	NULL
HH	NULL
,	NULL
Moroni	NULL
C.	NULL
Apoptosis	NULL
in	NULL
HIV-infected	NULL
individuals	NULL
is	NULL
an	NULL
early	NULL
marker	NULL
occuring	NULL
independently	NULL
of	NULL
high	NULL
viremia	NULL
.	NULL

AIDS	NULL
Res	NULL
Hum	NULL
Retrovir	NULL
1997	NULL
;	NULL
13:771-9	NULL
.	NULL

8	NULL
Kanner	NULL
SB	NULL
,	NULL
Haffar	NULL
OK.	NULL
HIV-1	NULL
down-regulates	NULL
CD4	NULL
costimulation	NULL
of	NULL
TCR/CD3-directed	NULL
tyrosine	NULL
phosphorylation	NULL
through	NULL
CD4/pS6lck	NULL
dissociation	NULL
.	NULL

J	NULL
Immunol	NULL
1995	NULL
;	NULL
154:96-3005	NULL
.	NULL

©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL
380	NULL
9	NULL
10	NULL
1	NULL
a	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
Guntermann	NULL
C	NULL
,	NULL
Dye	NULL
J	NULL
,	NULL
Nye	NULL
KE	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
abolishes	NULL
CD4-dependent	NULL
activation	NULL
of	NULL
ZAP-70	NULL
by	NULL
inhibition	NULL
of	NULL
p56/ick	NULL
.	NULL

J	NULL
Acquir	NULL
Immune	NULL
Defic	NULL
Syndr	NULL
Hum	NULL
Retrovir	NULL
1997	NULL
;	NULL
14:204-12	NULL
.	NULL

Ankel	NULL
H	NULL
,	NULL
Capobianchi	NULL
MR	NULL
,	NULL
Frezza	NULL
F	NULL
,	NULL
Castilletti	NULL
C	NULL
,	NULL
Dianzani	NULL
F.	NULL
Interferon	NULL
induction	NULL
by	NULL
HIV-l-infected	NULL
cells	NULL
:	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
sulfatides	NULL
or	NULL
related	NULL
glycolipids	NULL
.	NULL

Virology	NULL
1996	NULL
;	NULL
221:113-9	NULL
.	NULL

Hesselgesser	NULL
J	NULL
,	NULL
Taub	NULL
D	NULL
,	NULL
Baskar	NULL
P	NULL
et	NULL
al	NULL
.	NULL

Neuronal	NULL
apoptosis	NULL
induced	NULL
by	NULL
HIV-1	NULL
gp120	NULL
and	NULL
the	NULL
chemokine	NULL
SDF-l	NULL
«	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
.	NULL

Curr	NULL
Biol	NULL
1998	NULL
;	NULL
8:595-8	NULL
.	NULL

Capobianchi	NULL
MR	NULL
,	NULL
Mattana	NULL
P	NULL
,	NULL
Mercuri	NULL
F	NULL
et	NULL
al	NULL
.	NULL

Acid	NULL
lability	NULL
is	NULL
not	NULL
an	NULL
intrinsic	NULL
property	NULL
of	NULL
interferon	NULL
induced	NULL
by	NULL
HIV-infected	NULL
cells	NULL
.	NULL

J	NULL
Interferon	NULL
Res	NULL
1992	NULL
;	NULL
12:431-8	NULL
.	NULL

Capobianchi	NULL
MR	NULL
,	NULL
Ameglio	NULL
F	NULL
,	NULL
Cordiali	NULL
Fei	NULL
P	NULL
et	NULL
al	NULL
.	NULL

Coordinate	NULL
induction	NULL
of	NULL
IFN-alpha	NULL
and	NULL
-gamma	NULL
by	NULL
recombinant	NULL
HIV-1	NULL
glycoprotein	NULL
120	NULL
.	NULL

AIDS	NULL
Res	NULL
Hum	NULL
Retrovir	NULL
1993	NULL
;	NULL
9:957-62	NULL
.	NULL

Ameglio	NULL
F	NULL
,	NULL
Capobianchi	NULL
MR	NULL
,	NULL
Castilletti	NULL
C	NULL
et	NULL
al	NULL
.	NULL

Recombinant	NULL
gp120	NULL
induces	NULL
IL-10	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Correlation	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
cytokines	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
1994	NULL
;	NULL
95:455-8	NULL
.	NULL

Capobianchi	NULL
MR	NULL
,	NULL
Barresi	NULL
C	NULL
,	NULL
Borghi	NULL
P	NULL
et	NULL
al	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
gp120	NULL
stimulates	NULL
cytomegalovirus	NULL
replication	NULL
in	NULL
mono-cytes	NULL
:	NULL
possible	NULL
role	NULL
of	NULL
endogenous	NULL
interleukin-8	NULL
.	NULL

J	NULL
Virol	NULL
1997	NULL
;	NULL
71:1591-7	NULL
.	NULL

Abbate	NULL
I	NULL
,	NULL
Carletti	NULL
F	NULL
,	NULL
Dianzani	NULL
F	NULL
,	NULL
Capobianchi	NULL
MR.	NULL
RANTES	NULL
up-regulation	NULL
by	NULL
HIV-l-infected	NULL
cells	NULL
:	NULL
lack	NULL
of	NULL
correlation	NULL
with	NULL
viral	NULL
replication	NULL
and	NULL
induction	NULL
of	NULL
interferon	NULL
.	NULL

AIDS	NULL
1999	NULL
;	NULL
13:288-90	NULL
.	NULL

Pericle	NULL
F	NULL
,	NULL
Pinto	NULL
LA	NULL
,	NULL
Hicks	NULL
S	NULL
et	NULL
al	NULL
.	NULL

HIV-1	NULL
infection	NULL
induces	NULL
a	NULL
selective	NULL
induction	NULL
in	NULL
STATS	NULL
protein	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
1998	NULL
;	NULL
160:28-31	NULL
.	NULL

Lehtonen	NULL
A	NULL
,	NULL
Matikainen	NULL
S	NULL
,	NULL
Julkunen	NULL
I.	NULL
Interferons	NULL
up-regulate	NULL
STATI	NULL
,	NULL
STAT2	NULL
,	NULL
and	NULL
IRF	NULL
family	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

J	NULL
Immunol	NULL
1997	NULL
;	NULL
159:794-803	NULL
.	NULL

Boloventa	NULL
C	NULL
,	NULL
Lorini	NULL
AL	NULL
,	NULL
Mantelli	NULL
B	NULL
et	NULL
al	NULL
.	NULL

A	NULL
selective	NULL
defect	NULL
of	NULL
IFN-gamma-	NULL
but	NULL
not	NULL
of	NULL
IFN	NULL
alpha-induced	NULL
JAK/STAT	NULL
pathway	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
U937	NULL
clones	NULL
prevents	NULL
the	NULL
antiretroviral	NULL
effect	NULL
of	NULL
IFN-gamma	NULL
against	NULL
HIV-1	NULL
.	NULL

J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:323-30	NULL
.	NULL

Tamura	NULL
T	NULL
,	NULL
Ishihara	NULL
M	NULL
,	NULL
Lamphier	NULL
MS	NULL
et	NULL
al	NULL
.	NULL

DNA	NULL
damage-induced	NULL
apoptosis	NULL
and	NULL
Ice	NULL
gene	NULL
induction	NULL
in	NULL
mitogenically	NULL
activated	NULL
T	NULL
lymphocytes	NULL
require	NULL
IRF-1	NULL
.	NULL

Leukemia	NULL
1997	NULL
;	NULL
Suppl	NULL
.	NULL

3:439-40	NULL
.	NULL

Takeout	NULL
R	NULL
,	NULL
Tsutsumi	NULL
H	NULL
,	NULL
Osaki	NULL
M	NULL
,	NULL
Haseyama	NULL
K	NULL
,	NULL
Mizue	NULL
N	NULL
,	NULL
Chiba	NULL
S.	NULL
Respiratory	NULL
syncytial	NULL
virus	NULL
infection	NULL
of	NULL
human	NULL
alveolar	NULL
epithelial	NULL
cells	NULL
enhances	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
and	NULL
interleukin-1	NULL
beta-converting	NULL
enzyme	NULL
gene	NULL
expression	NULL
but	NULL
does	NULL
not	NULL
cause	NULL
apoptosis	NULL
.	NULL

J	NULL
Virol	NULL
1998	NULL
;	NULL
72:4498-502	NULL
.	NULL

Percario	NULL
ZA	NULL
,	NULL
Giandomenico	NULL
V	NULL
,	NULL
Fiorucci	NULL
G	NULL
et	NULL
al	NULL
.	NULL

Retinoic	NULL
acid	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
in	NULL
squamous	NULL
carcinoma	NULL
cells	NULL
via	NULL
a	NULL
STAT-1	NULL
independent	NULL
signalling	NULL
pathway	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
1999	NULL
;	NULL
10:263-70	NULL
.	NULL

Antonelli	NULL
G	NULL
,	NULL
Simeoni	NULL
E	NULL
,	NULL
Turriziani	NULL
O	NULL
et	NULL
al	NULL
.	NULL

Correlation	NULL
of	NULL
interferon-induced	NULL
expression	NULL
of	NULL
MxA	NULL
mRNA	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
I.	NULL
Abbate	NULL
,	NULL
F.	NULL
Dianzani	NULL
&	NULL
M.	NULL
R.	NULL
Capobianchi	NULL
cells	NULL
with	NULL
the	NULL
response	NULL
of	NULL
patients	NULL
with	NULL
chronic	NULL
active	NULL
hepatitis	NULL
C	NULL
to	NULL
IFN-	NULL
«	NULL
therapy	NULL
.	NULL

J	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
1999	NULL
;	NULL
19:243-51	NULL
.	NULL

Bitsch	NULL
A	NULL
,	NULL
Kirchner	NULL
H	NULL
,	NULL
Dupke	NULL
R	NULL
,	NULL
Bein	NULL
G.	NULL
Cytomegalovirus	NULL
transcript	NULL
in	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
of	NULL
actively	NULL
infected	NULL
transplant	NULL
patients	NULL
detected	NULL
by	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

J	NULL
Infect	NULL
Dis	NULL
1993	NULL
;	NULL
167:740-3	NULL
.	NULL

Agresti	NULL
C	NULL
,	NULL
Bemardo	NULL
A	NULL
,	NULL
Del	NULL
Russo	NULL
N	NULL
et	NULL
al	NULL
.	NULL

Synergistic	NULL
stimulation	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
and	NULL
IRF-1	NULL
gene	NULL
expression	NULL
by	NULL
IFN-gamma	NULL
and	NULL
TNF-alpha	NULL
in	NULL
oligodendrocytes	NULL
.	NULL

Eur	NULL
J	NULL
Neurosci	NULL
1998	NULL
;	NULL
9:2975-83	NULL
.	NULL

Blanco	NULL
J	NULL
,	NULL
Jacotot	NULL
E	NULL
,	NULL
Cabrera	NULL
C	NULL
et	NULL
al	NULL
.	NULL

The	NULL
implication	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
in	NULL
HIV-1	NULL
envelope	NULL
protein-induced	NULL
apoptosis	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
G	NULL
protein-mediated	NULL
signalling	NULL
.	NULL

AIDS	NULL
1999	NULL
;	NULL
13:909-17	NULL
.	NULL

Banda	NULL
NK	NULL
,	NULL
Bernier	NULL
J	NULL
,	NULL
Kurahara	NULL
DK	NULL
et	NULL
al	NULL
.	NULL

Crosslinking	NULL
CD4	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gp120	NULL
primes	NULL
T	NULL
cells	NULL
for	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1992	NULL
;	NULL
176:1099-106	NULL
.	NULL

Castilletti	NULL
C	NULL
,	NULL
Frezza	NULL
F	NULL
,	NULL
Abbate	NULL
I	NULL
,	NULL
Dianzani	NULL
F	NULL
,	NULL
Capobianchi	NULL
MR	NULL
.	NULL

Induction	NULL
of	NULL
interferon	NULL
by	NULL
HIV	NULL
:	NULL
possible	NULL
correlation	NULL
with	NULL
commitment	NULL
to	NULL
apoptosis	NULL
.	NULL

Eur	NULL
Cytokine	NULL
Network	NULL
1998	NULL
;	NULL
9:446	NULL
.	NULL

Berndt	NULL
C	NULL
,	NULL
Mopps	NULL
B	NULL
,	NULL
Angermuller	NULL
S	NULL
,	NULL
Gierschik	NULL
P	NULL
,	NULL
Krammer	NULL
PH	NULL
.	NULL

CXCR4	NULL
and	NULL
CD4	NULL
mediate	NULL
a	NULL
rapid	NULL
CD95-independent	NULL
cell	NULL
death	NULL
in	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
1998	NULL
;	NULL
95:12556-61	NULL
.	NULL

Zheng	NULL
J	NULL
,	NULL
Ghorpade	NULL
A	NULL
,	NULL
Niemann	NULL
D	NULL
et	NULL
al	NULL
.	NULL

Lymphotropic	NULL
virions	NULL
affect	NULL
chemokine	NULL
receptor-mediated	NULL
neural	NULL
signaling	NULL
and	NULL
apoptosis	NULL
:	NULL
implications	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1-associated	NULL
dementia	NULL
.	NULL

J	NULL
Virol	NULL
1999	NULL
;	NULL
73:8256-67	NULL
.	NULL

Herbein	NULL
G	NULL
,	NULL
Mahlknecht	NULL
U	NULL
,	NULL
Batliwalla	NULL
F	NULL
et	NULL
al	NULL
.	NULL

Apoptosis	NULL
of	NULL
CD8+	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
macrophages	NULL
through	NULL
interaction	NULL
of	NULL
HIV	NULL
gp120	NULL
with	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
.	NULL

Nature	NULL
1998	NULL
;	NULL
395:189-94	NULL
.	NULL

Kolesnick	NULL
R	NULL
,	NULL
Golde	NULL
DW	NULL
.	NULL

The	NULL
sphingomyelin	NULL
pathway	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
signaling	NULL
.	NULL

Cell	NULL
1994	NULL
;	NULL
77:325-8	NULL
.	NULL

Gamen	NULL
S	NULL
,	NULL
Anel	NULL
A	NULL
,	NULL
Pineiro	NULL
A	NULL
,	NULL
Naval	NULL
J.	NULL
Caspases	NULL
are	NULL
the	NULL
main	NULL
executioners	NULL
of	NULL
Fas-mediated	NULL
apoptosis	NULL
,	NULL
irrespective	NULL
of	NULL
the	NULL
ceramide	NULL
signalling	NULL
pathway	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
1998	NULL
;	NULL
5:241-9	NULL
.	NULL

Lee	NULL
KY	NULL
,	NULL
Anderson	NULL
E	NULL
,	NULL
Madani	NULL
K	NULL
,	NULL
Rosen	NULL
GD	NULL
.	NULL

Loss	NULL
of	NULL
STATI	NULL
expression	NULL
confers	NULL
resistance	NULL
to	NULL
IFN-gamma-induced	NULL
apoptosis	NULL
in	NULL
ME180	NULL
cells	NULL
.	NULL

FEBS	NULL
Letters	NULL
1999	NULL
;	NULL
459:323-6	NULL
.	NULL

Kano	NULL
A	NULL
,	NULL
Haruyama	NULL
T	NULL
,	NULL
Akaike	NULL
T	NULL
,	NULL
Watanabe	NULL
Y.	NULL
IRF-1	NULL
is	NULL
an	NULL
essential	NULL
mediator	NULL
in	NULL
IFN-gamma-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
apoptosis	NULL
of	NULL
primary	NULL
cultured	NULL
hepatocytes	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
1999	NULL
;	NULL
257:672-7	NULL
.	NULL

Luttmann	NULL
W	NULL
,	NULL
Dauer	NULL
E	NULL
,	NULL
Schmidt	NULL
S	NULL
$	NULL
et	NULL
al	NULL
.	NULL

Effects	NULL
of	NULL
interferon-gamma	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
on	NULL
CD95/Fas	NULL
Ligand-mediated	NULL
apoptosis	NULL
in	NULL
human	NULL
blood	NULL
eosinophils	NULL
Scand	NULL
J	NULL
Immunol	NULL
2000	NULL
;	NULL
51:54-59	NULL
.	NULL

Kayagaki	NULL
N	NULL
,	NULL
Yamaguchi	NULL
N	NULL
,	NULL
Nakayama	NULL
M	NULL
,	NULL
Eto	NULL
H	NULL
,	NULL
Okumura	NULL
K	NULL
,	NULL
Yagita	NULL
H.	NULL
Type	NULL
I	NULL
interferons	NULL
(	NULL
IFNs	NULL
)	NULL
regulate	NULL
tumor	NULL
necrosis	NULL
factor-related	NULL
apoptosis-inducing	NULL
ligand	NULL
(	NULL
TRAIL	NULL
)	NULL
expression	NULL
on	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
for	NULL
the	NULL
antitumor	NULL
effects	NULL
of	NULL
type	NULL
I	NULL
IFNs	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1999	NULL
;	NULL
189:1451-60	NULL
.	NULL

Marrack	NULL
P	NULL
,	NULL
Kappler	NULL
J	NULL
,	NULL
Mitchell	NULL
T.	NULL
Type	NULL
I	NULL
interferons	NULL
keep	NULL
activated	NULL
cells	NULL
alive	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1999	NULL
;	NULL
189:521-30	NULL
.	NULL

©	NULL
2000	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
122:374-380	NULL

